NanoEcho AB (publ)
Research NanoEcho AB (publ) (XT4) on Bullrun: market cap EUR 86.79K. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerXT4
- ExchangeF
- CountrySweden
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 86.79K
- Financial periodQ1 2026
- RevenueSEK 0
- Net income-SEK 5.22M
- Free cash flow-SEK 4.67M
Valuation Snapshot
latest market cap is EUR 86.79K.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | n/a | n/a | n/a | n/a | -0.06 | SEK 2.13M | SEK 0 | SEK 14.73M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-15 | EUR 86.79K | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About NanoEcho AB (publ)
NanoEcho AB (publ) engages in developing a new diagnostic method to determine the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is headquartered in Lund, Sweden.
Related stock research
Other Healthcare stocks
Camurus AB (0RD1)
Flerie AB (publ) (1NP1)
GENOVIS AB SE-40 (5GV)
Fluicell AB (publ) (5J90)
ExpreS2ion Biotech Holding AB (publ) (5JD0)
ALZINOVA AB (78D)
7AL0 (7AL0)
ASCELIA PHARMA AB (7ZA)
Biosergen AB (8N10)
ABERA BIOSCIENCE AB (8WK)
Ascelia Pharma AB (publ) (ACE)
AcouSort AB (ACOU)
Frequently asked questions
What is NanoEcho AB (publ)'s market cap?
NanoEcho AB (publ)'s market capitalization is EUR 86.79K.
What does NanoEcho AB (publ) do?
NanoEcho AB (publ) engages in developing a new diagnostic method to determine the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is headquartered in Lund, Sweden.